SMARCB1 and cancer: This C>T substitution which results in a truncated SMARCB1 protein is not reported in the general human population (dbSNP v137) but is the second most common SMARCB1 mutation reported in the catalogue of somatic mutations in cancer, Cosmic database (June 2013) (Figure 2).